Pharmabiz16m
Clearside Biomedical presents additional data from CLS-AX ODYSSEY phase 2b trial at Angiogenesis, Exudation & Degeneration 2025 meeting
Alpharetta, Georgia Wednesday, February 12, 2025, 16:30 Hrs [IST] ...
Pharmabiz46m
INmune Bio to submit BLA with US FDA seeking approval of CORDStrom to treat recessive dystrophic epidermolysis bullosa in paediatric patients
Boca Raton, Florida Wednesday, February 12, 2025, 16:00 Hrs [IST] ...
Pharmabiz1h
Nivaan Care pain management clinic chain raises $4.25 million in seed fund from Endiya Partners and W Health Ventures
Nivaan Care pain management clinic chain raises $4.25 million in seed fund from Endiya Partners and W Health Ventures: Our Bureau, Bengaluru Wednesday, February 12, 2025, 15:30 Hr ...
Pharmabiz2h
Researchers find influenza A viruses adapt shape in response to environmental pressures
Researchers find influenza A viruses adapt shape in response to environmental pressures: Bethesda, Maryland Wednesday, February 12, 2025, 14:00 Hrs [IST] Influenza A virus particl ...
Pharmabiz3h
EMA establishes regular procedure for scientific advice on certain high-risk medical devices
EMA establishes regular procedure for scientific advice on certain high-risk medical devices: Amsterdam, The Netherlands Wednesday, February 12, 2025, 13:00 Hrs [IST] EMA, in clos ...
Pharmabiz4h
Boehringer Ingelheim’s FIBRONEER-ILD phase III study of nerandomilast to treat progressive pulmonary fibrosis meets primary endpoint
Boehringer Ingelheim’s FIBRONEER-ILD phase III study of nerandomilast to treat progressive pulmonary fibrosis meets primary endpoint: Ingelheim, Germany Wednesday, February 12, ...
Pharmabiz4h
Glenmark Pharmaceuticals introduces clindamycin phosphate foam, 1%
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of clindamycin phosphate foam, 1%. Glenmark’s clindamycin phosphate foam, 1% is bioequivalent and therapeutically equivalent to the ...
Pharmabiz5h
National Organization for Rare Disorders issues new report on lifesaving newborn screening programmes
National Organization for Rare Disorders issues new report on lifesaving newborn screening programmes: Washington, D.C. Wednesday, February 12, 2025, 11:00 Hrs [IST] The National ...
Pharmabiz7h
Pfizer & Astellas’ Padcev plus Keytruda shows long-term efficacy in first-line treatment of locally advanced or metastatic urothelial cancer
Pfizer & Astellas’ Padcev plus Keytruda shows long-term efficacy in first-line treatment of locally advanced or metastatic urothelial cancer: New York Wednesday, February 12, 20 ...
Pharmabiz8h
Pharmexcil announces business delegation to Zambia, Tanzania & DR Congo from March 24 to April 1
Pharmexcil announces business delegation to Zambia, Tanzania & DR Congo from March 24 to April 1: Shardul Nautiyal, Mumbai Wednesday, February 12, 2025, 08:00 Hrs [IST] The Pharma ...
Pharmabiz8h
Indian healthcare industry keen on paving way for accessible & scalable precision medicine
Indian healthcare industry keen on paving way for accessible & scalable precision medicine: Nandita Vijayasimha, Bengaluru Wednesday, February 12, 2025, 08:00 Hrs [IST] Indian hea ...